胰高血糖素样肽-1受体激动剂与自杀倾向——需谨慎对待 - Suppr

Suppr

超能文献

GLP-1 Receptor Agonists and Suicidality-Caution Is Needed.

作者信息

Salvo Francesco, Faillie Jean-Luc

机构信息

Université de Bordeaux, INSERM, BPH, Team AHeaD, U1219, Bordeaux, France.

Service de Pharmacologie Médicale, CHU de Bordeaux, INSERM, U1219, Bordeaux, France.

出版信息

JAMA Netw Open. 2024 Aug 1;7(8):e2423335. doi: 10.1001/jamanetworkopen.2024.23335.

DOI:10.1001/jamanetworkopen.2024.23335

PMID:39163050

Abstract

摘要

相似文献

GLP-1 Receptor Agonists and Suicidality-Caution Is Needed.胰高血糖素样肽-1受体激动剂与自杀倾向——需谨慎对待

JAMA Netw Open. 2024 Aug 1;7(8):e2423335. doi: 10.1001/jamanetworkopen.2024.23335.

Glucagon-like peptide-1 receptor agonists and risk of suicidality among patients with type 2 diabetes: active comparator, new user cohort study.胰高血糖素样肽-1受体激动剂与2型糖尿病患者的自杀风险：活性对照新使用者队列研究

BMJ. 2025 Feb 26;388:e080679. doi: 10.1136/bmj-2024-080679.

Preliminary Review Finds No Link Between GLP-1 Receptor Agonists and Suicidality.初步审查发现胰高血糖素样肽-1受体激动剂与自杀行为之间无关联。

Am J Nurs. 2024 May 1;124(5):20. doi: 10.1097/01.NAJ.0001016352.54091.a1. Epub 2024 Apr 25.

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and suicidality: what do we know and future vistas.胰高血糖素样肽-1受体激动剂（GLP-1 RAs）与自杀行为：我们了解什么及未来展望

Expert Opin Drug Saf. 2024 May;23(5):539-542. doi: 10.1080/14740338.2024.2335215. Epub 2024 Mar 26.

The association between glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and suicidality: reports to the Food and Drug Administration Adverse Event Reporting System (FAERS).胰高血糖素样肽-1受体激动剂（GLP-1 RAs）与自杀倾向之间的关联：向美国食品药品监督管理局不良事件报告系统（FAERS）提交的报告

Expert Opin Drug Saf. 2024 Jan;23(1):47-55. doi: 10.1080/14740338.2023.2295397. Epub 2023 Dec 19.

Association of GLP-1 Receptor Agonists With Risk of Suicidal Ideation and Behaviour: A Systematic Review and Meta-Analysis.胰高血糖素样肽-1受体激动剂与自杀意念及行为风险的关联：一项系统评价和荟萃分析

Diabetes Metab Res Rev. 2025 Feb;41(2):e70037. doi: 10.1002/dmrr.70037.

Glucagon-Like Peptide-1 Receptor Agonists and Risk for Suicidal Ideation and Behaviors in U.S. Older Adults With Type 2 Diabetes : A Target Trial Emulation Study.胰高血糖素样肽-1 受体激动剂与美国老年 2 型糖尿病患者自杀意念和行为风险：一项目标试验模拟研究。

Ann Intern Med. 2024 Aug;177(8):1004-1015. doi: 10.7326/M24-0329. Epub 2024 Jul 16.

Association of glucagon-like peptide-1 receptor agonists with suicidal ideation and self-injury in individuals with diabetes and obesity: a propensity-weighted, population-based cohort study.胰高血糖素样肽-1 受体激动剂与糖尿病和肥胖个体的自杀意念和自残行为的关联：一项基于倾向评分的基于人群的队列研究。

Diabetologia. 2024 Nov;67(11):2471-2480. doi: 10.1007/s00125-024-06243-z. Epub 2024 Aug 6.

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and suicidality: A replication study using reports to the World Health Organization pharmacovigilance database (VigiBase®).胰高血糖素样肽-1 受体激动剂（GLP-1 RAs）与自杀：一项使用向世界卫生组织药物警戒数据库（VigiBase®）报告进行的复制研究。

J Affect Disord. 2025 Jan 15;369:922-927. doi: 10.1016/j.jad.2024.10.062. Epub 2024 Oct 19.

Association between glucagon-like peptide-1 receptor agonists and risk of suicidality: A comprehensive analysis of the global pharmacovigilance database.胰高血糖素样肽-1 受体激动剂与自杀风险的关联：全球药物警戒数据库的综合分析。

Diabetes Obes Metab. 2024 Nov;26(11):5183-5191. doi: 10.1111/dom.15864. Epub 2024 Aug 19.

引用本文的文献

Semaglutide: a key medication for managing cardiovascular-kidney-metabolic syndrome.司美格鲁肽：治疗心血管-肾脏-代谢综合征的关键药物。

Future Cardiol. 2025 Jul;21(9):663-683. doi: 10.1080/14796678.2025.2511412. Epub 2025 Jun 3.

Repurposing Antidiabetic Drugs for Cerebrovascular Diseases: Causal Evidence from Drug Target Mendelian Randomization and Colocalization.将抗糖尿病药物用于治疗脑血管疾病：来自药物靶点孟德尔随机化和共定位分析的因果证据

Mol Neurobiol. 2025 Apr 29. doi: 10.1007/s12035-025-04987-2.

Glucagon-like Peptide-1 Receptor Agonists: Exciting Avenues Beyond Weight Loss.胰高血糖素样肽-1受体激动剂：减肥之外的令人兴奋的途径。

J Clin Med. 2025 Mar 14;14(6):1978. doi: 10.3390/jcm14061978.

Suicide and Self-Harm Events With GLP-1 Receptor Agonists in Adults With Diabetes or Obesity: A Systematic Review and Meta-Analysis.糖尿病或肥胖症成人使用胰高血糖素样肽-1受体激动剂后的自杀和自我伤害事件：一项系统评价和荟萃分析。

JAMA Psychiatry. 2025 Mar 19. doi: 10.1001/jamapsychiatry.2025.0091.

Pharmacogenomic Assessment of Glucagon-like Peptide-1 (GLP1) Agonists and the Genetic Addiction Risk Score (GARS) Related Pathways: Implications for Suicidal Ideation and Substance Use Disorder.胰高血糖素样肽-1（GLP1）激动剂的药物基因组学评估及与遗传成瘾风险评分（GARS）相关的途径：对自杀意念和物质使用障碍的影响

Curr Neuropharmacol. 2025;23(8):974-995. doi: 10.2174/011570159X349579241231080602.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验